India's drug price regulator backs ban on combination drugs

The National Pharmaceutical Pricing Authority has asked pharma companies to review if their drug formulations have "irrational" fixed dose combinations.

from IBTimes.co.in : Science http://ift.tt/22EEekK

Commentaires

Posts les plus consultés de ce blog